{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:33:03Z","timestamp":1784086383194,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biopha.2016.09.052","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T02:02:34Z","timestamp":1474682554000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection?"],"prefix":"10.1016","volume":"84","author":[{"given":"Gheorghe","family":"Gluhovschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florica","family":"Gadalean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gluhovschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Velciov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia","family":"Petrica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviu","family":"Bob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe","family":"Bozdog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Kaycsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.09.052_bib0005","first-page":"37","article-title":"Urinary tract infection in patients with solitary kidney","volume":"5","author":"Gluhovschi","year":"1998","journal-title":"Facta Universitatis"},{"issue":"3 (Pt. 2)","key":"10.1016\/j.biopha.2016.09.052_bib0010","first-page":"F324","article-title":"Nephron adaptation to renal injury or ablation","volume":"249","author":"Brenner","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2016.09.052_bib0015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3109\/0886022X.2013.828367","article-title":"Is the urinary biomarkers assessment a non-invasive approach to tubular lesions of the solitary kidney","volume":"35","author":"Gadalean","year":"2013","journal-title":"Ren. Fail."},{"key":"10.1016\/j.biopha.2016.09.052_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s101560170023","article-title":"Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis","volume":"7","author":"Takahashi","year":"2001","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.biopha.2016.09.052_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/14740338.2013.796362","article-title":"Risks associated with the therapeutic use of fluoroquinolones","volume":"12","author":"Stahlmann","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2016.09.052_bib0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000168458","article-title":"Ciprofloxacin-induced acute interstitial nephritis","volume":"12","author":"Bailey","year":"1992","journal-title":"Am J. Nephrol."},{"key":"10.1016\/j.biopha.2016.09.052_bib0035","series-title":"The Sanford Guide to Antimicrobial Therapy 2010","author":"Gilbert","year":"2010"},{"key":"10.1016\/j.biopha.2016.09.052_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14712\/18059694.2018.35","article-title":"The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment","volume":"48","author":"Sk\u00e1lov\u00e1","year":"2005","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.biopha.2016.09.052_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jcp.36.3.253","article-title":"Alpha-1-microglobulin: an indicator protein for renal tubular function","volume":"36","author":"Yu","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2016.09.052_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1503\/cmaj.061590","article-title":"Urine proteomics: the present and future of measuring urinary protein components in disease","volume":"177","author":"Barratt","year":"2007","journal-title":"CMAJ"},{"issue":"Suppl","key":"10.1016\/j.biopha.2016.09.052_bib0055","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2016.09.052_bib0060","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI105772","article-title":"Functional correlates of compensatory renal hypertrophy","volume":"47","author":"Hayslett","year":"1968","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.052_bib0065","first-page":"68","article-title":"Microproteinuria and enzymuria in fever and pyelonephritis in childhood. A prospective study of 180 children","volume":"36","author":"Zoller","year":"1997","journal-title":"Urologe A"},{"key":"10.1016\/j.biopha.2016.09.052_bib0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5414\/NHP33285","article-title":"Utilization of urinary NAG elimination in the evaluation and nephrotoxicity of UTI treatment with amikacin","volume":"33","author":"Gluhovschi","year":"2004","journal-title":"Nieren-und Hochdruckkrankheiten"},{"key":"10.1016\/j.biopha.2016.09.052_bib0075","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.5414\/NHP34458","article-title":"Tubular lesions during renal colic with and without associated urinary tract infections(UTIs) evaluated by the determination of urinary N-acetyl-\u00df-d glucosaminidase(NAG)","volume":"10","author":"Gluhovschi","year":"2005","journal-title":"Nieren-und Hochdruckkrankheiten"},{"key":"10.1016\/j.biopha.2016.09.052_bib0080","first-page":"503","article-title":"Evaluation of N-acetyl-beta glucosaminidase in upper and lower urinary tract infections in childhood. Clinical study of 168 children","volume":"48","author":"Belli","year":"1996","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.biopha.2016.09.052_bib0085","first-page":"135","article-title":"N-acetyl-beta-glucosaminidase in the localization of the site of urinary tract infections","volume":"31","author":"Chan","year":"1990","journal-title":"Singapore Med. J."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2016.09.052_bib0090","first-page":"33","article-title":"Application of antibiotics in vulnerable groups","volume":"63","author":"Turkulov","year":"2010","journal-title":"Med. Pregl."},{"key":"10.1016\/j.biopha.2016.09.052_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ndt\/11.2.393a","article-title":"Ciprofloxacin-induced acute interstitial nephritis","volume":"11","author":"Reece","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.biopha.2016.09.052_bib0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1081\/JDI-120022557","article-title":"Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia","volume":"25","author":"Lim","year":"2003","journal-title":"Ren. Fail."},{"issue":"July (7)","key":"10.1016\/j.biopha.2016.09.052_bib0105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0025-6196(12)65160-X","article-title":"Allergic nephropathy associated with ciprofloxacin","volume":"65","author":"Rastogi","year":"1990","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.052_bib0110","first-page":"75","article-title":"Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature","volume":"32","author":"Hootkins","year":"1989","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.biopha.2016.09.052_bib0115","doi-asserted-by":"crossref","DOI":"10.1053\/ajkd.1998.v31.pm9531191","article-title":"Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes","author":"Dharnidharka","year":"1998","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.biopha.2016.09.052_bib0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archinte.1993.00410100082012","article-title":"Ciprofloxacin-induced nephrotoxicity in patients with cancer","volume":"153","author":"Lo","year":"1993","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.biopha.2016.09.052_bib0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1569-1993(03)00059-6","article-title":"Ciprofloxacin-induced renal insufficiency in cystic fibrosis","volume":"2","author":"Moffett","year":"2003","journal-title":"J. Cryst. Fibros."},{"issue":"5","key":"10.1016\/j.biopha.2016.09.052_bib0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000238444","article-title":"Crystalluria and ciprofloxacin, influence of urinary pH and hydration","volume":"32","author":"Thorsteinsson","year":"1986","journal-title":"Chemotherapy"},{"issue":"July (10)","key":"10.1016\/j.biopha.2016.09.052_bib0135","doi-asserted-by":"crossref","first-page":"E475","DOI":"10.1503\/cmaj.121730","article-title":"Risk of acute kidney injury associated with the use of fluoroquinolones","volume":"185","author":"Bird","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.biopha.2016.09.052_bib0140","first-page":"240","article-title":"Ciprofloxacin-induced crystal nephropathy","volume":"8","author":"Kammoun","year":"2014","journal-title":"Iran J. Kidney Dis."},{"key":"10.1016\/j.biopha.2016.09.052_bib0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nbt0510-436","article-title":"Next-generation biomarkers for detecting kidney toxicity","volume":"28","author":"Bonventre","year":"2010","journal-title":"Nat. Biotechnol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216310708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:48:09Z","timestamp":1773874089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216310708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":29,"alternative-id":["S0753332216310708"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.052","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}